Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TGFB1 Antikörper (AA 279-390)

TGFB1 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Maus Monoclonal C3 unconjugated
Produktnummer ABIN7427291
  • Target Alle TGFB1 Antikörper anzeigen
    TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
    Bindungsspezifität
    • 53
    • 16
    • 16
    • 15
    • 9
    • 8
    • 8
    • 8
    • 7
    • 6
    • 5
    • 5
    • 4
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 279-390
    Reaktivität
    • 172
    • 108
    • 53
    • 23
    • 20
    • 15
    • 12
    • 11
    • 8
    • 7
    • 5
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    Ratte
    Wirt
    • 194
    • 43
    • 3
    • 2
    • 1
    • 1
    • 1
    Maus
    Klonalität
    • 198
    • 46
    Monoklonal
    Konjugat
    • 96
    • 35
    • 31
    • 13
    • 8
    • 5
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    Dieser TGFB1 Antikörper ist unkonjugiert
    Applikation
    • 178
    • 92
    • 67
    • 53
    • 52
    • 43
    • 35
    • 34
    • 29
    • 19
    • 18
    • 11
    • 5
    • 5
    • 3
    • 2
    • 2
    • 2
    • 1
    Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
    Verwendungszweck
    Monoclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)
    Spezifität
    The antibody is a mouse monoclonal antibody raised against TGFb1. It has been selected for its ability to recognize TGFb1 in immunohistochemical staining and western blotting.
    Aufreinigung
    Protein A + Protein G affinity chromatography
    Immunogen
    Recombinant Transforming Growth Factor Beta 1 (TGFb1) corresdonding to Ala279~Ser390 with N-terminal His Tag
    Klon
    C3
    Isotyp
    IgG2b kappa
    Top Product
    Discover our top product TGFB1 Primärantikörper
  • Applikationshinweise

    Western blotting: 0.5-2 μg/mL

    1:500-2000 Immunohistochemistry: 5-20 μg/mL

    1:50-200 Immunocytochemistry: 5-20 μg/mL

    1:50-200 Optimal working dilutions must be determined by end user.

    Kommentare

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
    Haltbarkeit
    24 months
  • Target
    TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
    Andere Bezeichnung
    Transforming Growth Factor Beta 1 (TGFB1 Produkte)
    Synonyme
    CED antikoerper, DPD1 antikoerper, LAP antikoerper, TGFB antikoerper, TGFbeta antikoerper, TGF-beta antikoerper, TGF-BETA-1 antikoerper, TGF-beta5 antikoerper, ced antikoerper, dpd1 antikoerper, lap antikoerper, tgf-beta antikoerper, tgfb antikoerper, tgfb5 antikoerper, tgfbeta antikoerper, TGF-beta1 antikoerper, TGFbeta1 antikoerper, Tgfb antikoerper, Tgfb-1 antikoerper, ai39657 antikoerper, tgfb1 antikoerper, wu:fb13a07 antikoerper, xx:ai39657 antikoerper, TGFB1 antikoerper, csd antikoerper, cdb1 antikoerper, cdg2 antikoerper, csd1 antikoerper, csd2 antikoerper, csd3 antikoerper, ebmd antikoerper, lcd1 antikoerper, bigh3 antikoerper, cdgg1 antikoerper, betaig-h3 antikoerper, TGFB4 antikoerper, transforming growth factor beta 1 antikoerper, transforming growth factor beta-1 antikoerper, transforming growth factor beta 1 L homeolog antikoerper, transforming growth factor, beta 1 antikoerper, transforming growth factor, beta 1a antikoerper, transforming growth factor beta induced L homeolog antikoerper, TGFB1 antikoerper, Tgfb1 antikoerper, tgfb1.L antikoerper, tgfb1a antikoerper, tgfbi.L antikoerper
    Hintergrund
    TGF-B1, CED, DPD1, LAP, Camurati-Engelmann Disease, Latency-associated peptide
    Pathways
    EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie, Cancer Immune Checkpoints
Sie sind hier:
Kundenservice